Skip to main content

Luisa Maria Martinez Sánchez

Institutions of which they are part

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Luisa Maria Martinez Sánchez

Institutions of which they are part

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Análisis bioinformático masivo

IP: Albert Blanco Grau, Luisa Maria Martinez Sánchez

Projects

Detección temprana de recurrencia para una terapia personalizada en pacientes hormono-sensibles con cáncer de próstata metastásico.

IP: -
Collaborators: Luisa Maria Martinez Sánchez, Maria Eugenia Semidey Raven, Jacques Planas Morin
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 108900
Reference: RTI2018-096055-B-I00
Duration: 01/01/2019 - 30/09/2022

Related news

The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into clinical practice.

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Related professionals

Mª Ángeles Muchada López

Mª Ángeles Muchada López

Main researcher
Stroke research
Read more
Elena Lopez Cancio Martínez

Elena Lopez Cancio Martínez

Postdoctoral researcher
Neurovascular Diseases
Read more
Raquel Albertos  Martell

Raquel Albertos Martell

Shock, Organ Dysfunction and Resuscitation
Read more
Tamara Jimenez Martin

Tamara Jimenez Martin

403
Clinical Research Development Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.